Evaluation the Clinical Value of Ventilation/perfusion SPECT in Patients with Pulmonary Embolism and Anticoagulant Therapy

Jingjing Meng,Hongzhi Mi,Xiaoli Zhang,Xiang Li

2018-01-01

Abstract:1569 Objectives: To evaluate the clinical value of ventilation/perfusion single photon emission computed tomography (V/Q SPECT) in patients with pulmonary embolism (PE) and anticoagulant therapy by using V/Q SPECT and indentify factors which may affect the effect of therapy. Material and method: A total of 195 patients who underwent V/Q SPECT in Anzhen Hospital from July 2014 till December 2016 were clinically diagnosed as PE. Sixty-three patients who performed more than twice V/Q SPECT examinations were recruited in our current study. According to extent of lung perfusion defect (PD) involved lung volume (%), the severity of PE was defined as mild ( 50%). Further, according to the changes of PD at follow-up, patients were considered to be treated effectively, if the extent of lung PD decreased≥50% or no new PD was detected. Further, according to the mean pulmonary artery pressure (mPAP) measured by echocardiography, patients were defined as normal ( 0.05). The prevalence of PAH was higher in patients with severe (80.0%, 12/15) and moderate PE (66.7%, 16/24) than that in patients with mild PE (41.7%, 10/24) (p 0.05). (2) After 8.0±4.6 months V/Q SPECT scan were followed-up, 25 patients (40%) was treated effectively and 38 patients (60%) did not. 49% of patients with normal or mild PAH (n=45) were treated effectively, while only 17% with moderate and severe PAH (n=18) were treated effectively (χ2=5.577, p